What are the emerging drug treatments for Parkinson’s disease (1)

Opicapone as an adjunct to levodopa in patients with Parkinson’s disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial Ferreira JJ, Lees A, Rocha JF, et al; Bi-Park 1 investigators. Lancet Neurol 2016; 15:154-165 Abstract BACKGROUND: Opicapone is a novel, once-daily, potent third-generation catechol-O-methyltransferase inhibitor. We aimed to assess the safety and efficacy of […]

via What are the emerging drug treatments for Parkinson’s disease (1)? — Neurochecklists Updates

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s